FR2979522A1 - Systeme de conservation biodermique - Google Patents
Systeme de conservation biodermique Download PDFInfo
- Publication number
- FR2979522A1 FR2979522A1 FR1157861A FR1157861A FR2979522A1 FR 2979522 A1 FR2979522 A1 FR 2979522A1 FR 1157861 A FR1157861 A FR 1157861A FR 1157861 A FR1157861 A FR 1157861A FR 2979522 A1 FR2979522 A1 FR 2979522A1
- Authority
- FR
- France
- Prior art keywords
- cosmetic composition
- polyol
- anisic acid
- advantageously
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- ZEYHEAKUIGZSGI-UHFFFAOYSA-N 4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1 ZEYHEAKUIGZSGI-UHFFFAOYSA-N 0.000 title claims abstract description 37
- 239000000203 mixture Substances 0.000 title claims abstract description 32
- 239000002537 cosmetic Substances 0.000 title claims abstract description 24
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 title claims abstract description 14
- 229920005862 polyol Polymers 0.000 title claims abstract description 12
- 108700042778 Antimicrobial Peptides Proteins 0.000 title claims abstract description 11
- 102000044503 Antimicrobial Peptides Human genes 0.000 title claims abstract description 11
- 150000003077 polyols Chemical class 0.000 title claims abstract description 11
- 239000003910 polypeptide antibiotic agent Substances 0.000 title claims abstract description 11
- 239000003755 preservative agent Substances 0.000 title claims abstract description 11
- 230000002335 preservative effect Effects 0.000 title abstract description 6
- 238000004321 preservation Methods 0.000 claims description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 19
- 239000000126 substance Substances 0.000 claims description 7
- 244000088415 Raphanus sativus Species 0.000 claims description 5
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 4
- 235000007265 Myrrhis odorata Nutrition 0.000 claims description 3
- 240000004760 Pimpinella anisum Species 0.000 claims description 3
- 235000012550 Pimpinella anisum Nutrition 0.000 claims description 3
- 240000008042 Zea mays Species 0.000 claims description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 3
- 239000000839 emulsion Substances 0.000 claims description 3
- 239000000499 gel Substances 0.000 claims description 3
- 239000006210 lotion Substances 0.000 claims description 3
- 235000010676 Ocimum basilicum Nutrition 0.000 claims description 2
- 240000007926 Ocimum gratissimum Species 0.000 claims description 2
- 244000263375 Vanilla tahitensis Species 0.000 claims description 2
- 235000012036 Vanilla tahitensis Nutrition 0.000 claims description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 2
- 239000003963 antioxidant agent Substances 0.000 claims description 2
- 230000003078 antioxidant effect Effects 0.000 claims description 2
- 230000010261 cell growth Effects 0.000 claims description 2
- 239000002738 chelating agent Substances 0.000 claims description 2
- 235000005822 corn Nutrition 0.000 claims description 2
- 239000001963 growth medium Substances 0.000 claims description 2
- -1 peptide a polyol Chemical class 0.000 claims description 2
- 239000004094 surface-active agent Substances 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 description 8
- 230000003833 cell viability Effects 0.000 description 8
- 238000009472 formulation Methods 0.000 description 8
- 230000009471 action Effects 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 230000000843 anti-fungal effect Effects 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 238000011081 inoculation Methods 0.000 description 5
- 210000002510 keratinocyte Anatomy 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 244000052616 bacterial pathogen Species 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000002538 fungal effect Effects 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000228212 Aspergillus Species 0.000 description 2
- 241000228245 Aspergillus niger Species 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical class OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N Lactic Acid Natural products CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 231100000518 lethal Toxicity 0.000 description 2
- 230000001665 lethal effect Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 125000001453 quaternary ammonium group Chemical group 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- JOOXCMJARBKPKM-UHFFFAOYSA-M 4-oxopentanoate Chemical compound CC(=O)CCC([O-])=O JOOXCMJARBKPKM-UHFFFAOYSA-M 0.000 description 1
- 101710170232 Antimicrobial peptide 3 Proteins 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- UDHXJZHVNHGCEC-UHFFFAOYSA-N Chlorophacinone Chemical compound C1=CC(Cl)=CC=C1C(C=1C=CC=CC=1)C(=O)C1C(=O)C2=CC=CC=C2C1=O UDHXJZHVNHGCEC-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241001269524 Dura Species 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000192132 Leuconostoc Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 235000019057 Raphanus caudatus Nutrition 0.000 description 1
- 235000011380 Raphanus sativus Nutrition 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229940058352 levulinate Drugs 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012009 microbiological test Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000003873 salicylate salts Chemical class 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940080321 sodium anisate Drugs 0.000 description 1
- 229940058349 sodium levulinate Drugs 0.000 description 1
- AETSDHMVQHOYPB-UHFFFAOYSA-M sodium;4-methoxybenzoate Chemical compound [Na+].COC1=CC=C(C([O-])=O)C=C1 AETSDHMVQHOYPB-UHFFFAOYSA-M 0.000 description 1
- RDKYCKDVIYTSAJ-UHFFFAOYSA-M sodium;4-oxopentanoate Chemical compound [Na+].CC(=O)CCC([O-])=O RDKYCKDVIYTSAJ-UHFFFAOYSA-M 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/50—Isolated enzymes; Isolated proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
Abstract
Description
Claims (1)
- REVENDICATIONS1/ Système de conservation comprenant : - un peptide antimicrobien un polyol, avantageusement du propanediol ; de l'acide anisique. 2/ Système de conservation selon la revendication 1, caractérisé en ce que le peptide antimicrobien est obtenu à partir de radis. 3/ Système de conservation selon l'une des revendications précédentes, caractérisé en ce que le polyol, avantageusement le propanediol, est obtenu à partir de maïs. 41 Système de conservation selon l'une des revendications précédentes, caractérisé en ce que l'acide anisique est obtenu à partir de basilic, d'anis vert ou de vanille tahitienne. 5/ Système de conservation selon l'une des revendications précédentes, caractérisé en ce qu'il comprend en outre de l'alcool, avantageusement de l'éthanol, 6/ Composition cosmétique comprenant un système de conservation selon l'une des revendications 1 à 5. 7/ Composition cosmétique selon la revendication 6, caractérisée en ce que le peptide antimicrobien représente de 0,5 à 1% en poids, avantageusement 0,5%. 8/ Composition cosmétique selon la revendication 6 ou 7, caractérisée en ce que le polyol, avantageusement le propanediol, représente de 2 à 10% en poids, 30 avantageusement 5%. 9/ Composition cosmétique selon l'une des revendications 6 à 8, caractérisée en ce que l'acide anisique représente de 0,1 à 0,5% en poids, avantageusement 0,15%. 35 10/ Composition cosmétique selon l'une des revendications 6 à 9, caractérisée en ce que l'alcool représente de J à 5% en poids, avantageusement 2%.11/ Composition cosmétique selon l'une des revendications 6 à 10, caractérisée en ce qu'elle comprend un milieu de croissance cellulaire. 12/ Composition cosmétique selon l'une des revendications 6 à 11, caractérisée en ce qu'elle se présente sous forme d'émulsion, de lotion, de crème ou de gel. 13/ Composition cosmétique selon l'une des revendications 6 à 12, caractérisée en ce qu'elle comprend en outre au moins un composant choisi dans la liste suivante : un antioxydant, un agent chélatant et un tensioactif 14/ Composition cosmétique selon l'une des revendications 6 à 13, caractérisée en ce qu'elle est exempte de conservateur chimique.10
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1157861A FR2979522B1 (fr) | 2011-09-05 | 2011-09-05 | Systeme de conservation biodermique |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1157861A FR2979522B1 (fr) | 2011-09-05 | 2011-09-05 | Systeme de conservation biodermique |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2979522A1 true FR2979522A1 (fr) | 2013-03-08 |
FR2979522B1 FR2979522B1 (fr) | 2013-08-23 |
Family
ID=44983636
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR1157861A Active FR2979522B1 (fr) | 2011-09-05 | 2011-09-05 | Systeme de conservation biodermique |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2979522B1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113318054A (zh) * | 2021-05-10 | 2021-08-31 | 上海高庄生物科技有限公司 | 一种化妆品防腐组合物及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1325731A1 (fr) * | 2002-01-07 | 2003-07-09 | L'oreal | Agent microbicide et composition de traitement cosmétique le contenant |
EP1709955A1 (fr) * | 2005-04-08 | 2006-10-11 | Dr. Straetmans GmbH | Solutions aqueuses concentrées d' acide p-methoxybenzoique destinés à être utilisés dans de produits cosmétiques ou dermatologiques |
KR20100020124A (ko) * | 2008-08-12 | 2010-02-22 | 두두원발효(주) | 복합 김치유산균으로 발효한 콩 발효물을 유효성분으로 함유하는 피부 미백 및 주름제거용 화장료 조성물 |
JP2010059132A (ja) * | 2008-09-05 | 2010-03-18 | Shift:Kk | 抗菌剤 |
WO2011011703A1 (fr) * | 2009-07-23 | 2011-01-27 | Professional Compounding Centers Of America, Ltd. | Mélange conservateur naturel |
-
2011
- 2011-09-05 FR FR1157861A patent/FR2979522B1/fr active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1325731A1 (fr) * | 2002-01-07 | 2003-07-09 | L'oreal | Agent microbicide et composition de traitement cosmétique le contenant |
EP1709955A1 (fr) * | 2005-04-08 | 2006-10-11 | Dr. Straetmans GmbH | Solutions aqueuses concentrées d' acide p-methoxybenzoique destinés à être utilisés dans de produits cosmétiques ou dermatologiques |
KR20100020124A (ko) * | 2008-08-12 | 2010-02-22 | 두두원발효(주) | 복합 김치유산균으로 발효한 콩 발효물을 유효성분으로 함유하는 피부 미백 및 주름제거용 화장료 조성물 |
JP2010059132A (ja) * | 2008-09-05 | 2010-03-18 | Shift:Kk | 抗菌剤 |
WO2011011703A1 (fr) * | 2009-07-23 | 2011-01-27 | Professional Compounding Centers Of America, Ltd. | Mélange conservateur naturel |
Non-Patent Citations (3)
Title |
---|
"AMS Leucidal Liquid", 22 January 2010 (2010-01-22), XP002668445, Retrieved from the Internet <URL:http://www.lotioncrafter.com/reference/Tech_Data_Leucidal_Liquid_v6.pdf> [retrieved on 20120131] * |
DATABASE WPI Week 201023, Derwent World Patents Index; AN 2010-D15572, XP002668442 * |
DATABASE WPI Week 201101, Derwent World Patents Index; AN 2010-L57408, XP002668443 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113318054A (zh) * | 2021-05-10 | 2021-08-31 | 上海高庄生物科技有限公司 | 一种化妆品防腐组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
FR2979522B1 (fr) | 2013-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2995531A1 (fr) | Procede d'extraction et de stabilisation de phycocyanine et ses applications | |
FR3036618A1 (fr) | Extraits vegetaux destines a la cosmetique, solvants et procedes pour les obtenir | |
EP1000542B1 (fr) | Système à activité antimicrobienne et son utilisation, notamment dans les domaines cosmétique et dermatologique | |
FR2866564A1 (fr) | Desinfectant antiseptique et produit cosmetique, produit pharmaceutique ou aliment le contenant | |
AU2014301021B2 (en) | Synergistic preservative blends | |
Ozdemir et al. | Fabrication and characterization of basil essential oil microcapsule-enriched mayonnaise and its antimicrobial properties against Escherichia coli and Salmonella Typhimurium | |
FR3021531A1 (fr) | Systeme de conservation | |
EP3429346B1 (fr) | Composition comprenant un mel, un ester methylique d'acide gras et un tensioactif non-ionique de hlb superieur ou egal a 12 | |
FR2979522A1 (fr) | Systeme de conservation biodermique | |
CA2994931A1 (fr) | Systeme de conservation a base d'acides organiques | |
EP4258884A1 (fr) | Composition liquide antimicrobienne et son utilisation comme activateur de conservateur de produits cosmetiques | |
FR2866234A1 (fr) | Desinfectant antiseptique et produit cosmetique, produit pharmaceutique ou aliment le contenant | |
EP3429349B1 (fr) | Concentre comprenant un mel et un ester d'acide gras et de polyethylene glycol de hlb superieur ou egal a 12 | |
FR2968657A1 (fr) | Utilisation comme conservateur de derives dimethoxy-hydroxyphenyl-alkyl substitues, procede de conservation, compose et composition | |
FR3068208B1 (fr) | Melange antimicrobien contenant du 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one et de l’acide dehydroacetique ou l’un de ses sels , et composition cosmetique le contenant | |
EP1427387B1 (fr) | Produit cosmetique pour les soins de la peau | |
FR3064179A1 (fr) | Agent conservateur contenant de l'hinokitiol avec au moins un acide et compositions preservees par ledit agent | |
FR2992560A1 (fr) | Utilisation comme agent antipelliculaire d'une huile essentielle d'origan marjolaine, procede de traitement et composition la comprenant | |
FR3070112A1 (fr) | Melange antimicrobien contenant du 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one et d’un sel d’alkyltrimethylammonium, et composition cosmetique le contenant | |
US20240082125A1 (en) | Use of a short chain fatty acid as antidandruff agent | |
FR3068215B1 (fr) | Melange antimicrobien contenant du 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one et de l’acide n-octanoyl-5 salicylique, et composition cosmetique le contenant | |
FR3137289A1 (fr) | Système conservateur et composition associée | |
WO2023047072A1 (fr) | Systeme de conservation et methode de formulation ecobiologique respectant le microbiote cutane | |
FR3139992A1 (fr) | Procédé d’obtention d’une composition de métabolites d’algues à usage cosmétique, extraits et compositions issus d’un tel procédé et utilisation cosmétique de ces extraits et compositions | |
FR3137290A1 (fr) | Système conservateur et composition associée |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 5 |
|
PLFP | Fee payment |
Year of fee payment: 6 |
|
PLFP | Fee payment |
Year of fee payment: 7 |
|
PLFP | Fee payment |
Year of fee payment: 8 |
|
PLFP | Fee payment |
Year of fee payment: 9 |
|
PLFP | Fee payment |
Year of fee payment: 10 |
|
PLFP | Fee payment |
Year of fee payment: 11 |
|
PLFP | Fee payment |
Year of fee payment: 12 |
|
PLFP | Fee payment |
Year of fee payment: 13 |
|
AU | Other action affecting the ownership or exploitation of an industrial property right |
Effective date: 20231016 |
|
CL | Concession to grant licences |
Name of requester: NAOS, FR Effective date: 20231016 Name of requester: NAOS INSTITUTE OF LIFE SCIENCE, FR Effective date: 20231016 |